Intellia Therapeutics
Tristan Ng is a Senior Research Associate at Intellia Therapeutics, Inc. since April 2023, with prior experience as an Associate Scientist I at 2seventy bio, where responsibilities included producing mRNA for therapeutic applications and conducting analytics to assess product quality from November 2021 to April 2023. Tristan also served as an Associate Scientist I at bluebird bio for a brief period in September 2021 and worked as a Medical Technologist at Quest Diagnostics from August 2020 to September 2021. Educationally, Tristan holds a Bachelor of Arts in Biology from the University of Delaware, completed in 2020.
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.